SkinStasis Launches Patented Anti-Aging Serum with Breakthrough Use of Tranexamic Acid
FOR IMMEDIATE RELEASE
DALLAS, TX – SkinStasis Skin Care recently announced the launch of its Anti-Aging Glow Serum, which is a unique combination of three important and highly regarded ingredients: 10% Tranexamic Acid, Niacinamide (Vitamin B3) and Copper Tripeptide (GHK-Cu). The Glow Serum will complement the Cold Sore Care gel in SkinStasis’ innovative, science-based NextLeapTM brand of skin care products.
According to Co-Founder Frank Murdock: “The NextLeap Glow Serum is a multi-purpose anti-aging product. It reduces the appearance of fine lines and wrinkles, as well as skin discoloration from sun damage, melasma and other causes. It will help maintain firmness and elasticity, and just provides a healthy glow.”
Co-Founder Paul Stewart added: “The Glow Serum has several rare and even unique features. It helps promote the production of collagen and elastin like some other products, but it also appears to preserve the collagen and elastin you already have. Tranexamic Acid is a well-known cosmetic ingredient for addressing skin discoloration, but for the first time we are introducing its ability to reduce the appearance of fine lines and wrinkles. This use is covered by a U.S. patent, which is unusual in cosmetics.”
The NextLeap products are currently available online at Amazon, Walmart.com, the TikTok Shop and the nextleapskincare.com website. The NextLeap Glow Serum will address the $50 billion anti-aging cosmetics market that is growing 6% annually given global demographics and increased attention to protection against sun exposure.
Unlike many products used for wrinkles or discoloration, the Glow Serum does not cause increased sensitivity to sunlight. In fact its ingredients are considered to protect against the cosmetic effects of sun damage.
"The Glow Serum is a gentle, easily absorbed daily-use product,” said Murdock. “Compared to other high-quality anti-aging cosmetic products, it is very reasonably priced, despite the fact that it contains 10% Tranexamic Acid as well as other premium ingredients. We believe it has some unique features that will benefit many people."
Stewart and Murdock are former Pfizer executives and serial entrepreneurs who have been involved in the development of innovative new biotech and consumer products for many years, including the first hydroxyapatite bone cement, one of the earliest robotic surgery systems, and the Five Hour Energy product. They have been working on various cosmetic and ground-breaking medical uses of Tranexamic Acid for over ten years.
To learn more about NEXTLEAP™ and the Glow Serum, visit nextleapskincare.com.
About SkinStasis: SkinStasis Skin Care LLC is a Texas-based company with extensive expertise relating to Tranexamic Acid and its use in cosmetics. SkinStasis launched at the end of 2022 with an innovative Cold Sore Care product under the NextLeapTM brand, and conducted a successful crowdfunding raise through Wefunder in early 2024. SkinStasis was founded by Paul Stewart and Frank Murdock, who are former Pizer executives, veterans of the healthcare and consumer products industries, and successful serial entrepreneurs. They are supported by the highly successful investor Doug Rippeto, as well as by world-renowned plastic surgeon, scientist and educator Rod Rohrich, MD, Past President of the American Society of Plastic Surgeons, former Founding Chairman of the Department of Plastic Surgery of UT Southwestern Medical School, and Newsweek’s Best Plastic Surgeon in the US in multiple categories, among many other positions and honors.
For media inquiries, please contact:
Jeanann Grubbs, Hour One Agency